Skip to content
Thomson Reuters
Corporate Governance

Chemed to pay $75 million over false claims lawsuit: Justice Dept

Reuters Staff

30 Oct 2017

WASHINGTON (Reuters) – Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

The allegations relate to billing for ineligible patients and inflated levels of care, the department said in a statement. Vitas Hospice Services is the largest U.S. for-profit hospice chain, it said.

Reporting by Eric Walsh; Editing by Mohammad Zargham
Our Standards:The Thomson Reuters Trust Principles.
Conflicts and climate disasters forcing children into work – U.N. Godfather of investing for good says capitalism leaving people behind Trump urged to push North Korea to end slavery at Singapore summit EXCLUSIVE – Expose of labour abuse brews trouble for ‘slave-free’ Indian tea Enbridge hits debt target with $2.5 billion pipeline, renewables sale Nissan to gradually withdraw from diesel vehicle market in Europe Allianz cuts back on coal insurance after environmentalist criticism Corrupt officials to blame for loss of Kenya’s forest cover: government report Use blockchain to educate and empower refugees, says ExsulCoin CEO ‘Wake up call’ as luxury fashion brands criticised over supply chain slavery risk